This site is intended for Healthcare Professionals only.

Tag: thyroid drug


Tribunal upholds £84 million fine on Advanz Pharma, PE firms over drug price inflation

Advanz Pharma, alongside London-based private equity firms Cinven and HgCapital, is collectively confronted with an £84 million penalty for inflating the price of the...

CMA slaps Advanz with £100 million in fines for over pricing of thyroid drug

The Competition and Markets Authority (CMA) has imposed more than £100 million in fines on Advanz for inflating the price of thyroid tablets. The pharma...